Trading · Founded 1993 · www.shentracon.com · BSE 530757 · · ISIN INE0OUS01011
No Notes Added Yet
Business
Shentracon Chemicals Ltd. (or Shentracon Chemicals Private Limited, as it appears to be a private entity) is an Indian chemical company primarily engaged in the manufacturing, trading, and supply of various industrial chemicals. The company's product portfolio likely includes a range of acids, solvents, bulk chemicals, and specialty chemicals. It serves a diverse set of end-user industries such as pharmaceuticals, agrochemicals, textiles, water treatment, and food & beverages. The core business model involves producing these chemicals and selling them on a business-to-business (B2B) basis, earning revenue through the margins on manufacturing and distribution.
Revenue Mix
As a private company, detailed breakdowns of key segments and revenue contributions are not publicly available. However, based on the typical operations of chemical manufacturers, Shentracon Chemicals Ltd. likely segments its business by product categories (e.g., Bulk Chemicals, Specialty Chemicals, Solvents) or by target end-user industries (e.g., Pharmaceutical intermediates, Agrochemical raw materials).
Industry
Shentracon Chemicals operates within the highly diverse and competitive Indian Chemicals industry. The industry includes large, integrated multinational corporations, major Indian conglomerates, and numerous small to medium-sized enterprises. The sector is characterized by varying levels of competition, from commodity chemicals with intense price pressure to specialty chemicals requiring R&D and application expertise. Shentracon Chemicals is likely positioned as a mid-tier or niche player, competing by offering a specific range of products, catering to particular regional markets, or building strong relationships with industrial customers. Their competitive landscape includes both larger established players and other regional specialized manufacturers.
MOAT
For a company of its likely scale, Shentracon Chemicals' competitive advantages may stem from:
Established Customer Relationships: Long-standing relationships and reliable supply to industrial clients.
Operational Efficiency/Cost Structure: Optimized manufacturing processes or procurement strategies leading to competitive pricing.
Niche Product Expertise: Specialization in certain chemical formulations or applications that meet specific customer needs.
Distribution Network: An efficient supply chain or regional distribution strength in the Indian market.
Product Quality & Reliability: Consistent quality and on-time delivery can foster customer loyalty in the B2B chemical space.
Growth Drivers
Key factors that can drive Shentracon Chemicals' growth over the next 3-5 years include:
Growth in End-User Industries: Sustained expansion of key client sectors like pharmaceuticals, agrochemicals, and textiles within India.
"Make in India" Initiatives: Government emphasis on domestic manufacturing can boost demand for locally produced chemicals.
Product Portfolio Expansion: Introduction of new chemicals or entry into new specialty segments.
Increased Production Capacity: Investment in expanding manufacturing facilities to meet growing demand.
Market Share Gains: Acquisition of new customers or increased penetration in existing markets.
Risks
Raw Material Price Volatility: Fluctuations in the cost of crude oil derivatives or other key feedstocks can impact profitability.
Intense Competition: The fragmented Indian chemicals market can lead to price pressure and erosion of margins.
Regulatory & Environmental Compliance: Strict and evolving environmental norms can increase operational costs and require significant investments in compliance.
Demand Cyclicality: Demand for chemicals can be tied to the economic cycles of end-user industries.
Currency Fluctuations: For companies involved in import or export of raw materials/finished goods, currency movements pose a risk.
Management & Ownership
Shentracon Chemicals Ltd. appears to be a privately held company. Ownership is typically concentrated among the founders/promoters and potentially early investors. Management is likely led by the founding family or individuals with significant operational experience in the chemical industry. Information on specific management quality or detailed ownership structure is not publicly available for private entities.
Outlook
Shentracon Chemicals is positioned within the expanding Indian chemical sector, benefiting from domestic industrial growth and increasing demand from diverse end-user segments like pharma and agrochemicals. The company's ability to maintain strong customer relationships, innovate in product offerings, and manage operational efficiencies will be crucial. However, it faces inherent challenges typical of the industry, including exposure to raw material price volatility, intense competition from both domestic and international players, and evolving regulatory landscapes. Its growth trajectory will largely depend on strategic capital allocation, market adaptation, and effective cost management within a competitive environment.
| #(Fig in Cr.) | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenditure | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Profit | -0 | -0 | -0 | 0 | 0 | 0 | -0 | -0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | -0 | 0 | -0 | 0 | 0 | 0 |
| Profit Before Tax | -0 | -0 | -0 | 0 | -0 | 0 | -0 | -0 | 0 | 0 |
| Provision for Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Tax | -0 | -0 | -0 | 0 | -0 | 0 | -0 | -0 | 0 | 0 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 |
| Profit After Adjustments | -0 | -0 | -0 | 0 | -0 | 0 | -0 | -0 | 0 | 0 |
| Adjusted Earnings Per Share | -0.1 | -0.1 | -0.1 | 0.1 | -0.6 | 0.2 | -1.1 | -0 | 0.2 | 0 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenditure | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Profit | 0 | 0 | 0 | -0 | -0 | -0 | -0 | -0 | -0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | -0 | 0 |
| Profit Before Tax | 0 | 0 | 0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | 0 |
| Provision for Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Tax | 0 | 0 | 0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | 0 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 0 | 0 | 0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | 0 |
| Adjusted Earnings Per Share | 0 | 0 | 0 | -0.5 | -0.4 | -0.1 | -0.2 | -0.2 | -0.2 | -0.7 | -0.8 | -0.9 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 0% | 0% | 0% | 0% |
| Operating Profit CAGR | 0% | 0% | 0% | 0% |
| PAT CAGR | 0% | 0% | 0% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | 710% | NA% | NA% | NA% |
| ROE Average | 0% | 0% | 0% | 0% |
| ROCE Average | -27% | -19% | -14% | -7% |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 2 | 2 | -1 | -1 | -1 | -1 | -1 | -2 | -2 | -2 | -2 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 2 | 2 | 5 | 5 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 4 | 4 | 4 | 4 | 2 | 2 | 2 | 2 | 1 | 1 | 1 |
| Fixed Assets | 1 | 1 | 3 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 0 | 0 |
| Total Current Assets | 3 | 3 | 1 | 1 | 2 | 0 | 0 | 2 | 0 | 1 | 1 |
| Total Assets | 4 | 4 | 4 | 4 | 2 | 2 | 2 | 2 | 1 | 1 | 1 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 |
| Cash Flow from Operating Activities | -0 | 0 | 0 | -0 | -3 | -0 | -0 | -2 | 1 | -2 | -0 |
| Cash Flow from Investing Activities | 0 | 0 | 0 | 0 | 7 | -1 | -0 | 1 | -1 | 1 | 0 |
| Cash Flow from Financing Activities | -0 | -0 | -0 | 0 | -2 | -0 | 0 | 0 | -0 | 0 | 0 |
| Net Cash Inflow / Outflow | 0 | -0 | 0 | -0 | 2 | -1 | -0 | -0 | -0 | -0 | 0 |
| Closing Cash & Cash Equivalent | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| # | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 0 | 0 | 0 | -0.52 | -0.35 | -0.11 | -0.16 | -0.22 | -0.24 | -0.67 | -0.75 |
| CEPS(Rs) | 0.04 | 0.04 | 0.04 | -0.48 | -0.31 | -0.11 | -0.16 | -0.22 | -0.24 | -0.67 | -0.75 |
| DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Book NAV/Share(Rs) | -2.06 | -2.05 | -2.05 | -2.57 | -2.93 | -3.04 | -3.2 | -3.42 | -3.66 | -4.34 | -5.09 |
| Core EBITDA Margin(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 42.21 |
| EBIT Margin(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -199.1 |
| Pre Tax Margin(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -199.1 |
| PAT Margin (%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -199.1 |
| Cash Profit Margin (%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -199.1 |
| ROA(%) | 0 | 0.01 | 0 | -5.49 | -5.42 | -3.08 | -4.72 | -6.51 | -7.42 | -21.11 | -25.84 |
| ROE(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| ROCE(%) | 0.43 | 0.43 | 0.36 | -5.03 | -4.68 | -3.34 | -5.02 | -6.66 | -7.74 | -22.3 | -26.97 |
| Receivable days | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 328.61 |
| Inventory Days | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Payable days | 0 | 0 | 0 | 0 | 10.44 | 0 | 0 | 0 | 0 | 0 | 0 |
| PER(x) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Price/Book(x) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EV/Net Sales(x) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 46.32 |
| EV/Core EBITDA(x) | 253.55 | 253.3 | 274.19 | -50.69 | -50.22 | -143.8 | -100.58 | -78.67 | -72.4 | 503.35 | 109.74 |
| Net Sales Growth(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBIT Growth(%) | 153.59 | -0.56 | -16.23 | -1472.84 | 37.21 | 62.38 | -45.71 | -29.28 | -8.04 | -187.53 | -15.76 |
| PAT Growth(%) | 100.24 | 182.24 | -70.86 | 0 | 31.91 | 68.55 | -45.46 | -36.33 | -9.17 | -179.53 | -11.57 |
| EPS Growth(%) | 100.27 | 133.33 | -68.84 | 0 | 31.92 | 68.55 | -45.46 | -36.32 | -9.2 | -179.46 | -11.57 |
| Debt/Equity(x) | 1.34 | 1.31 | -5.61 | -4.58 | -2.16 | -2.07 | -1.99 | -1.9 | -1.75 | -1.71 | -1.49 |
| Current Ratio(x) | 11.51 | 10.47 | 2.94 | 2 | 6.81 | 0.92 | 0.27 | 5.05 | 0.46 | 4.2 | 3.15 |
| Quick Ratio(x) | 8.72 | 7.93 | 0.68 | 0.21 | 6.81 | 0.92 | 0.27 | 5.05 | 0.46 | 4.2 | 3.15 |
| Interest Cover(x) | 1.01 | 1.02 | 1.01 | -9.36 | -5 | -299.65 | -623.81 | -17.8 | -14.87 | -31.16 | 0 |
| Total Debt/Mcap(x) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 61.23 | 61.23 | 61.23 | 61.23 | 61.23 | 61.23 | 61.23 | 61.23 | 61.23 | 61.23 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 38.77 | 38.77 | 38.77 | 38.77 | 38.77 | 38.77 | 38.77 | 38.77 | 38.77 | 38.77 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.27 | 0.27 | 0.27 | 0.27 | 0.27 | 0.27 | 0.27 | 0.27 | 0.27 | 0.27 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.17 | 0.17 | 0.17 | 0.17 | 0.17 | 0.17 | 0.17 | 0.17 | 0.17 | 0.17 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 0.44 | 0.44 | 0.44 | 0.44 | 0.44 | 0.44 | 0.44 | 0.44 | 0.44 | 0.44 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | — | — | — | — |
| Operating Profit CAGR | — | — | — | — |
| PAT CAGR | — | — | — | — |
| Share Price CAGR | +710% | — | — | — |
| ROE Average | 0% | 0% | 0% | 0% |
| ROCE Average | -27% | -19% | -14% | -7% |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 61.23 | 61.23 | 61.23 | 61.23 | 61.23 | 61.23 | 61.23 | 61.23 | 61.23 | 61.23 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 38.77 | 38.77 | 38.77 | 38.77 | 38.77 | 38.77 | 38.77 | 38.77 | 38.77 | 38.77 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.27 | 0.27 | 0.27 | 0.27 | 0.27 | 0.27 | 0.27 | 0.27 | 0.27 | 0.27 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.17 | 0.17 | 0.17 | 0.17 | 0.17 | 0.17 | 0.17 | 0.17 | 0.17 | 0.17 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 0.44 | 0.44 | 0.44 | 0.44 | 0.44 | 0.44 | 0.44 | 0.44 | 0.44 | 0.44 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
Your relationship manager will connect with you shortly.